In vivo expression of Nurr1/Nr4a2a in developing retinal amacrine subtypes in zebrafish Tg(nr4a2a:eGFP) transgenics.
The Nuclear receptor subfamily 4 group A member 2 (Nr4a2) is crucial for the formation or maintenance of dopaminergic neurons in the central nervous system including the retina, where dopaminergic amacrine cells contribute to visual function. Little is known about which cells express Nr4a2 at which developmental stage. Furthermore, whether Nr4a2 functions in combination with other genes is poorly understood. Thus, we generated a novel transgenic to visualize Nr4a2 expression in vivo during zebrafish retinogenesis. A 4.1 kb fragment of the nr4a2a promoter was used to drive green fluorescent protein expression in this Tg(nr4a2a:eGFP) line. In situ hybridization showed that transgene expression follows endogenous RNA expression at a cellular level. Temporal expression and lineages were quantified using in vivo time-lapse imaging in embryos. Nr4a2 expressing retinal subtypes were characterized immunohistochemically. Nr4a2a:eGFP labeled multiple neuron subtypes including 24.5% of all amacrine interneurons. Nr4a2a:eGFP labels all tyrosine hydroxylase labeled dopaminergic amacrine cells, and other nondopaminergic GABAergic amacrine populations. Nr4a2a:eGFP is confined to a specific progenitor lineage identified by sequential expression of the bhlh transcription factor Atonal7 (Atoh7) and Pancreas transcription factor 1a (Ptf1a), and labels postmitotic postmigratory amacrine cells. Thus, developmental Nr4a2a expression indicates a role during late differentiation of specific amacrine interneurons. Tg(nr4a2a:eGFP) is an early marker of distinct neurons including dopaminergic amacrine cells. It can be utilized to assess consequences of gene manipulations and understand whether Nr4a2 only carries out its role in the presence of specific coexpressed genes. This will allow Nr4a2 use to be refined for regenerative approaches.
Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, Australia.
Liana
L
Goodings
Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, 200031, China.
Jie
J
He
Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, Australia.
Alasdair J
AJ
Wood
Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.
William A
WA
Harris
Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, Australia.
Peter D
PD
Currie
Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, Australia.|School of Biosciences, University of Melbourne, Parkville, Victoria, Australia.
Patricia R
http://orcid.org/0000-0003-0747-4084
PR
Jusuf
D025042:Amacrine Cells / Q000166:cytology* / Q000378:metabolism*; D000818:Animals; D030801:Animals, Genetically Modified; D002454:Cell Differentiation / Q000502:physiology; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D055495:Neurogenesis / Q000502:physiology*; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2 / Q000096:biosynthesis*; D059467:Transcriptome; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000096:biosynthesis*
D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D029961:Zebrafish Proteins
RRID: AB_2034060; RRID: AB_2034062; RRID: AB_2068506; RRID: AB_2079751; RRID: AB_213554; RRID: AB_2174013; RRID: AB_2201528; RRID: AB_2534023; RRID: AB_477522; RRID: AB_477652; RRID: AB_572253; amacrine; dopaminergic neurons; retina; transgenic; zebrafish